Targeting the IL1β Pathway for Cancer Immunotherapy Remodels the Tumor Microenvironment and Enhances Antitumor Immune Responses.

Overview of attention for article published in Cancer Immunology Research, April 2023

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (79th percentile)
Above-average Attention Score compared to outputs of the same age and source (56th percentile)

Mentioned by

twitter: 16 X users

Citations

dimensions_citation: 8 Dimensions

Readers on

mendeley: 7 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 21 X posts from 16 X users, with an upper bound of 19,487 followers.

RT @CIR_AACR: IL1β blockade enhances the efficacy of docetaxel and anti–PD1 in multiple cancer models. Find out about the changes occurring…

01 Jul 2023

Reply Repost Favourite

RT @CIR_AACR: IL1β blockade enhances the efficacy of docetaxel and anti–PD1 in multiple cancer models. Find out about the changes occurring…

01 Jul 2023

Reply Repost Favourite

RT @CIR_AACR: IL1β blockade enhances the efficacy of docetaxel and anti–PD1 in multiple cancer models. Find out about the changes occurring…

30 Jun 2023

Reply Repost Favourite

IL1β blockade enhances the efficacy of docetaxel and anti–PD1 in multiple cancer models. Find out about the changes occurring in the TME, in this study by Rohan Diwanji, Pushpa Jayaraman et al. https://t.co/scN1bxgO4O @NovartisScience https://t.co/mnNNs202

30 Jun 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 17 additional X posts.